OtoNexus Medical Technologies commercializes a patented medical device designed to diagnose middle ear infections.
OtoNexus Medical Technologies commercializes a patented medical device designed to diagnose middle ear infections in children and adults. It will allow clinicians to accurately identify viral vs. bacterial infection and determine whether an antibiotic is appropriate. The device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in the detection of otitis media. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 30, 2019 | Private Equity(PE) | $5M | 1 | — | — | Detail |
Mar 19, 2019 | Grant | $718.10K | 1 | National Science Foundation | — | Detail |
Jul 16, 2018 | Convertable Note | $2.50M | 1 | — | — | Detail |
Jul 10, 2017 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Keiretsu Forum | — | Private Equity(PE) |